Theme: Diabetes from Monitoring to Management

Diabetes 2016

Diabetes 2016

Being recognized as a world-renowned organization, OMICS International takes pride to introduce the commencement of “14th International Conference and Exhibition on Targeting Diabetes and Novel Therapeutics” from October 17-19, 2016 at Kuala Lumpur, Malaysia. Special interest and theme of this conference is: A step towards translating novel therapies to control Diabetes”. The conference aims to provide an opportunity to share knowledge, expertise along with unparalleled networking opportunities between a large number of medical and industrial professionals in this sphere. OMICS International’s Diabetes Medicare 2016 conference gathers renowned scientists, physicians, surgeons, young researchers, industrial delegates and talented student communities in the field of diabetic medicine under a single roof where networking and global partnering happens for the acceleration of future research.

OMICS Publishing Group through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. OMICS Publishing Group hosts over 400 leading-edge peer reviewed Open Access journals and has organized over 300 scientific conferences all over the world.

OMICS International welcomes all the scientists, physicians, surgeons, young researchers, industrial delegates and talented student communities in the field of diabetic medicine to attend this Diabetes Conferences, where all the aspects of diabetes will be discussed under single roof. Diabetes Medicare 2016 will be an excellent amalgamation of academia and industry as it involves every aspects of empirical and conceptual thinking in exploring new dimensions in this field.  It is open to all types of research methodologies both from academia and industry.

Diabetes Medicare 2016 is an international platform for presenting research about diabetes management and therapeutics, exchanging ideas about it and thus, contributes to the dissemination of knowledge in management of the disease for the benefit of the society. Diabetes Medicare 2016 is where the future of management and novel therapeutics for the disease intersects.

Diabetes has increasingly become a lifestyle-related disease as it afflicts young and old. In 2013, the value of the diabetes therapeutics market in Asia-Pacific (APAC) countries was an estimated $6.5 billion, and it is forecast to grow at a Compound Annual Growth Rate (CAGR) of 7.1% between 2013 and 2020 to $10.5 billion. The latest report states that of the four major APAC countries (China, India, Japan and Australia), China will see the fastest expansion, with a CAGR of 11.1% over the forecast period. This will be driven by an increase in the prevalent population due to urbanization, advancement in the lifestyle of the people and by expected drug launches.

- See more at: http://diabeticmedications.conferenceseries.com/#sthash.9t8EtRMO.dpuf

Being recognized as a world-renowned organization, Conferenceseries LLC takes pride to introduce the commencement of “12th World Congress on Diabetes"" from Sept 29-30, 2016 at Toronto, Canada. The conference aims to provide an opportunity to share knowledge, expertise along with unparalleled networking opportunities between a large number of medical and industrial professionals in this sphere. Conference series LLC’s Diabetes 2016 conference gathers renowned scientists, physicians, surgeons, young researchers, industrial delegates and talented student communities in the field of diabetic medicine under a single roof where networking and global partnering happens for the acceleration of future research.

Conference series LLC through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. Conference series LLC hosts over 400 leading-edge peer reviewed Open Access journals and has organized over 300 scientific conferences all over the world.

Conference Series LLC welcomes all the scientists, physicians, surgeons, young researchers, industrial delegates and talented student communities in the field of diabetic medicine to attend this Diabetes Conferences, where all the aspects of diabetes will be discussed under single roof. Diabetes Meeting 2016 will be an excellent amalgamation of academia and industry as it involves every aspects of empirical and conceptual thinking in exploring new dimensions in this field.  It is open to all types of research methodologies both from academia and industry.

Diabetes 2016 is an international platform for presenting research about diabetes management and therapeutics, exchanging ideas about it and thus, contributes to the dissemination of knowledge in management of the disease for the benefit of the society. Diabetes 2016 is where the future of management and novel therapeutics for the disease intersects.

CANADIAN INSTITUTIONS: HIGH IMPACT IN CLINICAL MEDICINE,

Listed by average citations per paper, among Canadian institutions whose affiliated authors published at least 500 papers between 2008 and 2012 in Thomson Reuters-indexed journals in the main field of Clinical Medicine, according to the journal-classification scheme employed for Essential Science Indicators.

Institution

Papers
2008-2012

Citations per
paper

McMaster University

4,768

13.28

Ottawa Hospital Research Institute

1,720

12.29

Université Laval

2,192

10.84

University of Ottawa

3,799

10.14

McGill University

5,996

10.03

SOURCE: Thomson Reuters Web of Science

 

Diabetes has increasingly become a lifestyle-related disease as it afflicts young and old. In 2013, the value of the diabetes therapeutics market in Asia-Pacific (APAC) countries was an estimated $6.5 billion, and it is forecast to grow at a Compound Annual Growth Rate (CAGR) of 7.1% between 2013 and 2020 to $10.5 billion. The latest report states that of the four major APAC countries (China, India, Japan and Australia), China will see the fastest expansion, with a CAGR of 11.1% over the forecast period. This will be driven by an increase in the prevalent population due to urbanization, advancement in the lifestyle of the people and by expected drug launches.

Track 1: Physiology of Diabetes


Diabetes is one of the most significant global health concerns of modern times. The causes of type 2 diabetes are multi-factorial and include both genetic and environmental elements that affect beta-cell function and tissue (muscle, liver, adipose tissue, and pancreas) insulin sensitivity. A number of factors have been suggested as possibly linking insulin resistance and beta-cell dysfunction in the pathogenesis of Type 2 Diabetes. A majority of individuals suffering from type 2 diabetes are obese, with central visceral adiposity. According to the International Diabetes Federation, diabetes statistics says that there are more than 317 million people have been diagnosed with diabetes, and an additional 187 million are living undiagnosed. The global revenue earned from drugs sales to treat Type 2 Diabetes was approximately $36.89 billion in 2012 that is rapidly increasing in incidence and prevalence across the globe predicated to elevate this figure to approximately $68.42 billion by 2017. Patients with this disease cannot use glucose properly for their body needs. Latest research on Diabetes has led to the better living of the diabetic patients. In addition to this, self-monitoring of Blood glucose levels, lifestyle modifications and health eating habits are crucial in combating the critical manifestations of this disease which may require proper diabetic nursing. This may also include considerable amount of time educating patients and families on proper dietary, exercise and lifestyle habits to keep symptoms under control.


Related Conferences:


6th Global Diabetes Summit and Meeting Expo, November 02-04, 2015, UAEInternational Conference on Thyroid Disorders and Treatment, February 29-March 02, 2016, USA11th Asia Pacific Diabetes Conference and Expo, July 11-13, 2016, Australia9th Global Diabetologists Annual Meeting and Expo, June 06-08, 2016, USA; 11th International Conference and Exhibition on Targeting Diabetes and Novel Therapeutics, October 17-19, 2016, Malaysia; Advanced Technologies & Treatments for Diabetes conference, Milan, Italy; New Therapeutics for Diabetes and Obesity conference, La Jolla, United States; Primary Care Update: Type 2 Diabetes, Metabolic Syndrome and Obesity Baltic Cruise conference, Copenhagen, Denmark; International Conference on Diabetes and Nutrition conference, Toronto Canada; Diabetes: New Insights into Molecular Mechanisms and Therapeutic Strategies conferences, Japan; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Conferences Nov 14-15, 2016 Dubai, UAE


Track 2: Clinical Diabetes and Diagnostic Approaches


Novel therapeutic targets available for diabetes includes Incretin based therapies, oral therapeutic agents like secretagogues, beta cell regeneration & proliferation and stem cell therapies.  Embryonic stem cell and fetal precursor cell transplantation therapies are the major stem cell therapies available for Diabetes. Apart from the above, various computational approaches in Diabetes management have been introduced recently with latest diabetes clinical trial going on which are playing an important role in identification of genes causing diabetes helping in Early Detection of Diabetes. These processes are also useful in studying the chemical etiologies of Diabetes uncovering various treatment prospects and model construction processes for survival prediction combating the complications of diabetes like Gestational Diabetes, Diabetes Myopathy, Diabetes cardiopathy and more.


Related Conferences:


6th Global Diabetes Summit and Meeting Expo, November 02-04, 2015, UAEInternational Conference on Thyroid Disorders and Treatment, February 29-March 02, 2016, USA11th Asia Pacific Diabetes Conference and Expo, July 11-13, 2016, Australia9th Global Diabetologists Annual Meeting and Expo, June 06-08, 2016, USA; 11th International Conference and Exhibition on Targeting Diabetes and Novel Therapeutics, October 17-19, 2016, Malaysia; Advanced Technologies & Treatments for Diabetes conference, Milan, Italy; New Therapeutics for Diabetes and Obesity conference, La Jolla, United States; Primary Care Update: Type 2 Diabetes, Metabolic Syndrome and Obesity Baltic Cruise conference, Copenhagen, Denmark; International Conference on Diabetes and Nutrition conference, Toronto Canada; Diabetes: New Insights into Molecular Mechanisms and Therapeutic Strategies conferences, Japan; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Conferences Nov 14-15, 2016 Dubai, UAE


Track 3: Diabetes and its Complications


With rising numbers of diagnosed diabetics, pharmaceutical manufacturers have capitalized on the burgeoning market for diabetes therapies. Manufacturers' efforts to develop non-invasive methods of insulin delivery are set to revolutionize the insulin therapy market, while demand for oral medications is on the upswing due to a growing Type 2 diabetic population and introduction of technologically advanced therapies for battling complications associated to Type 2 Diabetes like the most prevalent Diabetes Cardiomyopathy. With human embryonic stem cells as a starting point, the scientists are for the first time able to produce, in the kind of massive quantities needed for cell transplantation and pharmaceutical purposes, human insulin-producing beta cells equivalent in most every way to normally functioning beta cells. This will certainly help people recover the prognosis of the fatal disease like diabetes.


Related conferences:


6th Global Diabetes Summit and Meeting Expo, November 02-04, 2015, UAEInternational Conference on Thyroid Disorders and Treatment, February 29-March 02, 2016, USA11th Asia Pacific Diabetes Conference and Expo, July 11-13, 2016, Australia9th Global Diabetologists Annual Meeting and Expo, June 06-08, 2016, USA; 11th International Conference and Exhibition on Targeting Diabetes and Novel Therapeutics, October 17-19, 2016, Malaysia; Advanced Technologies & Treatments for Diabetes conference, Milan, Italy; New Therapeutics for Diabetes and Obesity conference, La Jolla, United States; Primary Care Update: Type 2 Diabetes, Metabolic Syndrome and Obesity Baltic Cruise conference, Copenhagen, Denmark; International Conference on Diabetes and Nutrition conference, Toronto Canada; Diabetes: New Insights into Molecular Mechanisms and Therapeutic Strategies conferences, Japan; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Conferences Nov 14-15, 2016 Dubai, UAE


Track 4: Diabetes Medications & Pharmacotherapy


The global diabetes treatment market is undergoing significant transition driven by the advent of new analytical technologies and developments in diabetes treatment. There has been a drastic increase in the incidents of diabetes worldwide, owing to the rising level of lifestyles and obesity in global population. The diabetes treatment products include injectable diabetes drugs, oral drugs, insulin therapies, insulin pumps, insulin injection devices and blood glucose monitoring systems which eliminates the risk of reverse diabetes. According to the new report the world market for diabetes medications will reach $55.3bn in 2017. The anti-diabetic medicines industry generated $35.6bn in 2012, and its revenues will show strong growth to 2023. Monitoring glucose levels is critical for the management of diabetes and new and improved portable, less costly, easy-to-use, accurate and virtually painless blood glucose monitoring systems are now available to take control of the disease.


Related Conferences:

6th Global Diabetes Summit and Meeting Expo, November 02-04, 2015, UAEInternational Conference on Thyroid Disorders and Treatment, February 29-March 02, 2016, USA11th Asia Pacific Diabetes Conference and Expo, July 11-13, 2016, Australia9th Global Diabetologists Annual Meeting and Expo, June 06-08, 2016, USA; 11th International Conference and Exhibition on Targeting Diabetes and Novel Therapeutics, October 17-19, 2016, Malaysia; Advanced Technologies & Treatments for Diabetes conference, Milan, Italy; New Therapeutics for Diabetes and Obesity conference, La Jolla, United States; Primary Care Update: Type 2 Diabetes, Metabolic Syndrome and Obesity Baltic Cruise conference, Copenhagen, Denmark; International Conference on Diabetes and Nutrition conference, Toronto Canada; Diabetes: New Insights into Molecular Mechanisms and Therapeutic Strategies conferences, Japan; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Conferences Nov 14-15, 2016 Dubai, UAE


Track 5: Alternative Therapies for Diabetes


Diabetes Mellitus is a dreadful disease and is found in all parts of the world, becoming a serious threat of mankind health. There are lots of chemical agents available to take control on the disease, but total recovery from diabetes is the question to the treatment. Alternative to these synthetic agents, natural cure by plants provides a potential source curing complications of hypoglycemia and reverse Diabetes are widely used in several traditional systems of medicine to prevent prediabetes. Other alternative therapies such as diabetic supplements, acupuncture, hydrotherapy, and yoga therapies are reported to have less likely side effects of conventional approaches for diabetes.


Related Conferences:


6th Global Diabetes Summit and Meeting Expo, November 02-04, 2015, UAEInternational Conference on Thyroid Disorders and Treatment, February 29-March 02, 2016, USA11th Asia Pacific Diabetes Conference and Expo, July 11-13, 2016, Australia9th Global Diabetologists Annual Meeting and Expo, June 06-08, 2016, USA; 11th International Conference and Exhibition on Targeting Diabetes and Novel Therapeutics, October 17-19, 2016, Malaysia; Advanced Technologies & Treatments for Diabetes conference, Milan, Italy; New Therapeutics for Diabetes and Obesity conference, La Jolla, United States; Primary Care Update: Type 2 Diabetes, Metabolic Syndrome and Obesity Baltic Cruise conference, Copenhagen, Denmark; International Conference on Diabetes and Nutrition conference, Toronto Canada; Diabetes: New Insights into Molecular Mechanisms and Therapeutic Strategies conferences, Japan; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Conferences Nov 14-15, 2016 Dubai, UAE


Track 6: Diabetes Market & Business Analysis


Diabetes has increasingly become a lifestyle-related disease as it afflicts young and old. As the number of patients grows across the globe, there has never been a stronger and more urgent need for novel therapeutic measures in clinical and preclinical evaluation, that arrest the growth of the disease. The diabetes market, consisting mainly of Type 1 and Type 2 diabetes, is large and growing significantly. The global market value for diabetes therapies and diagnostics has reached to $48.5 billion. The largest segment of the market, insulin products, is worth $20.8 billion in the recent times, including administration and diagnostic devices. Monitoring devices and other related equipment, the second-largest market is established with an investment of $13.5 billion in which was proposed for $11.3. The fastest-growing segment of oral diabetic complication of hypoglycemia drugs manufacturing funding is $14.13 in present scenario of diabetes market.


Related Conferences:


6th Global Diabetes Summit and Meeting Expo, November 02-04, 2015, UAEInternational Conference on Thyroid Disorders and Treatment, February 29-March 02, 2016, USA11th Asia Pacific Diabetes Conference and Expo, July 11-13, 2016, Australia9th Global Diabetologists Annual Meeting and Expo, June 06-08, 2016, USA; 11th International Conference and Exhibition on Targeting Diabetes and Novel Therapeutics, October 17-19, 2016, Malaysia; Advanced Technologies & Treatments for Diabetes conference, Milan, Italy; New Therapeutics for Diabetes and Obesity conference, La Jolla, United States; Primary Care Update: Type 2 Diabetes, Metabolic Syndrome and Obesity Baltic Cruise conference, Copenhagen, Denmark; International Conference on Diabetes and Nutrition conference, Toronto Canada; Diabetes: New Insights into Molecular Mechanisms and Therapeutic Strategies conferences, Japan; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Conferences Nov 14-15, 2016 Dubai, UAE


Track 7: Nutrition Therapy of Diabetes


With the growing awareness and information regarding preventive measures for combating fatal disease like diabetes, consumers are opting for proper food along with medicines. One can improve the health in a big way by making small changes to the diet, while still enjoying the favorite foods and taking pleasure from the meals. A diabetes diet is simply a healthy eating plan that is high in nutrients, low in fat, and moderate in calories. Manufacturers are now keen towards Diabetes Nutrition on introducing new low calorie food products with sugar substitutes and less oil, in view of the increasing consumer interest toward healthy eating and help prevent diabetes and its concomitant risk factors.


Related Conferences:


6th Global Diabetes Summit and Meeting Expo, November 02-04, 2015, UAEInternational Conference on Thyroid Disorders and Treatment, February 29-March 02, 2016, USA11th Asia Pacific Diabetes Conference and Expo, July 11-13, 2016, Australia9th Global Diabetologists Annual Meeting and Expo, June 06-08, 2016, USA; 11th International Conference and Exhibition on Targeting Diabetes and Novel Therapeutics, October 17-19, 2016, Malaysia; Advanced Technologies & Treatments for Diabetes conference, Milan, Italy; New Therapeutics for Diabetes and Obesity conference, La Jolla, United States; Primary Care Update: Type 2 Diabetes, Metabolic Syndrome and Obesity Baltic Cruise conference, Copenhagen, Denmark; International Conference on Diabetes and Nutrition conference, Toronto Canada; Diabetes: New Insights into Molecular Mechanisms and Therapeutic Strategies conferences, Japan; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Conferences Nov 14-15, 2016 Dubai, UAE


Track 8: Innovations in Diabetes Care and Management


Current Research in diabetes is focusing on developing Implantable insulin pumps which introduced Insulin pump therapy, disruption of fat metabolism, invasive and non-invasive glucose sensors, Artificial pancreas, New insulin delivery systems like inhaled, transdermal and implantable devices, Insulin Pens, Bariatric surgery and Conventional therapeutic approaches. Traditional approaches like Acupuncture and herbal medications are playing vital role in treatment of Diabetes and its related risk factors covering majorly obesity and Diabetes.


Related Conferences:


6th Global Diabetes Summit and Meeting Expo, November 02-04, 2015, UAEInternational Conference on Thyroid Disorders and Treatment, February 29-March 02, 2016, USA11th Asia Pacific Diabetes Conference and Expo, July 11-13, 2016, Australia9th Global Diabetologists Annual Meeting and Expo, June 06-08, 2016, USA; 11th International Conference and Exhibition on Targeting Diabetes and Novel Therapeutics, October 17-19, 2016, Malaysia; Advanced Technologies & Treatments for Diabetes conference, Milan, Italy; New Therapeutics for Diabetes and Obesity conference, La Jolla, United States; Primary Care Update: Type 2 Diabetes, Metabolic Syndrome and Obesity Baltic Cruise conference, Copenhagen, Denmark; International Conference on Diabetes and Nutrition conference, Toronto Canada; Diabetes: New Insights into Molecular Mechanisms and Therapeutic Strategies conferences, Japan; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Conferences Nov 14-15, 2016 Dubai, UAE

12th World Congress on Diabetes is going to be held during September 29- 30, 2016 at Toronto, Canada. Diabetic Medications conference gathers renowned scientists, physicians, surgeons, young researchers, industrial delegates and talented student communities in the field of diabetic medicine under a single roof where networking and global partnering happens for the acceleration of future research.

The conference throws light on thought provoking topics and recent research in the field of Diabetic Medications like, Type 1 Diabetes- Therapies and treatments, Type 2 Diabetes- Therapies and treatments, Diabetic Neuropathy-Treatment and Care, Management of Diabetic Heart Diseases, Management of Diabetic Kidney Diseases, Clinical Diabetic Therapeutics & Management, Islet Biology and Beta cell targeting, Computational Approaches for Diabetes, and many more. The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Diabetes Meeting 2016 International Conference, where you are sure to have a meaningful experience with scholars from around the world. All the Organizing Committee Members of the Diabetes 2016 International Conference look forward to meet you in Las Vegas, Nevada, USA.

Conference series LLC welcomes all the scientists, physicians, surgeons, young researchers, industrial delegates and talented student communities in the field of diabetic medicine to attend this Diabetes Conference, where all the aspects of diabetes will be discussed under single roof. Diabetes 2016 will be an excellent amalgamation of academia and industry as it involves every aspects of empirical and conceptual thinking in exploring new dimensions in this field.  It is open to all types of research methodologies both from academia and industry.

Diabetes 2016 is an international platform for presenting research about diabetes management and therapeutics, exchanging ideas about it and thus, contributing to the dissemination of knowledge in management of the disease for the benefit of the society. Diabetes 2016 is where the future of management and novel therapeutics for the disease intersects

For more details please visit- http://diabetesmeeting.conferenceseries.com/

Importance & Scope

Diabetes has increasingly become a lifestyle-related disease as it afflicts young and old. According to WHO Diabetes was estimated to affect 371 million people till the end of 2011in US. Whereas, new figures indicate that the number of people living with diabetes is expected to rise from 371 million in 2012 to 552 million by 2030. This indicates an urgent alarm for its management. As the number of patients grows across the globe, there has never been a stronger and more urgent need for therapeutic measures that arrest the growth of the disease and alleviate its secondary manifestations. In Type 1 diabetes total β-cell loss occurs. In Type 2 diabetes, partial β-cell loss occurs before diagnosis, and the progressive β-cell loss during the life of the patient increases the severity of the disease. This addresses novel therapies for these deficiencies in clinical and preclinical evaluation.

Many International Conferences and Diabetic therapies meetings/ symposium and workshops have been organized on different topics related to the risk factors related to diabetes across the globe such as glucose tolerability conference, diabetes stem cell cure conference, anti-diabetic agents meetings, obesity conferences, weight loss conferences, Islet transplantation international conference, glucose variability conferences etc. Besides that many international events such as diabetes alternative medicines events, insulin pump therapy events, pancreatic dysfunction events, recombinant approaches for diabetes events etc. Targeted Therapy Events have been also taking place in order to find a weapon against fatal diseases like diabetic foot, insulin resistance, glucose tolerability, obesity and to discuss the role of diabetes in cardiovascular diseases, kidney diseases, risk of cancer and intolerability to cure the wound which will gives a better insight about the associated causes and disease portfolio.

Why Toronto (Canada)?

The quality of surveillance information on diabetes in Canada has increased substantially over the last decade. The Canadian Chronic Disease Surveillance System uses population-based administrative data from every province and territory to provide detailed, comparative information for assessing the burden, as well as the use of health services and certain health outcomes of chronic diseases, including diabetes. Population surveys provide additional data on diabetes, its risk factors, complications and impacts on the lives of affected Canadians. The combination of these complementary data sources provides information to the Public Health Agency of Canada's diabetes surveillance program.

From 1998/99 to 2008/09, the prevalence of diagnosed diabetes among Canadians increased by 70%. The greatest relative increase in prevalence was seen in the 35 to 39 and 40 to 44 year age groups, where the proportion doubled. Likely, this increase in younger age groups is, in part, a consequence of increasing rates of overweight and obesity.

Hospitals Associated with Diabetes Research

Diabetes being one of the most fatal, most fast-growing diseases in the world with the maximum elevation rate in the incidence has best hospitals across the globe. Diabetes has maximum sufferings in China, USA and in the Asia pacific region giving a reason to have best management. Best Endocrinology hospitals as per the area are as follows:

Best Diabetes hospitals in Canada:

Over 29.1 million people (9.3 percent) of the U.S. population currently has diabetes, reports the Centers for Disease Control, and it is an epidemic that seems to be growing. Not only is diabetes detrimental to one’s health, but it is also a costly disease to treat. The total estimated cost of diagnosed diabetes in 2012 was $245 billion, according to the ADA, including $176 billion in direct medical costs and $69 billion in reduced productivity.

  1. Diabetes Clinic
  2. LMC Bayview
  3. Diabetes Education Centre
  4. LMC Endocrinology Centers
  5. Banting & Best Diabetes Centre
  6. LMC Etobicoke
  7. Toronto General Hospital
  8. St. Paul's Hospital
  9. Banff - Mineral Springs Hospital
  10. Juravinski Hospital

The high prevalence of the disease requires the best management and prevention obscuring the best hospitals around the world, especially in the highly prevalent areas.

 

Associations Associated with Diabetes Research

To encourage, educate, update and train registered medical practitioners, dieticians, qualified nurses and other appropriately qualified paramedical personnel in the field of Diabetes various well-known societies/associations are working across the globe to efficiently prevent and combat the fatal disease.


Major Diabetes Associations around the Globe

  1. Diabetes Indian Association
  2. Canadian Diabetes Association
  3. International Diabetes Federation
  4. Diabetes Australia
  5. Austrian Diabetes Association
  6. Diabetes UK
  7. Diabetes South Africa
  8. Spanish Diabetes Society (Spain)
  9. Swedish Diabetes Association
  10. Korean Diabetes Association

Universities Associated with Diabetes Research

There are around 5000 medical universities in the world out of which approximately 3000 universities focusing on Endocrinology and Diabetes researches.

Top Medical Universities for Diabetes in the world:

  1. Albany Medical College
  2. Baylor College of Medicine
  3. Creighton University School of Medicine
  4. Dartmouth Medical School
  5. Florida International University College of Medicine
  6. Georgetown University School of Medicine
  7. Howard University College of Medicine
  8. Harvard Medical School
  9. Johns Hopkins University School of Medicine
  10. Pennsylvania State University College of Medicine

 

Companies Associated with Diabetic products and their funding

 

Glance at Market of Diabetes

Global Market for Diabetes Therapies & Diagnostics is to be worth $51.2 billion in 2015. The diabetes market, consisting mainly of Type 1 and Type 2 diabetes, is large and growing significantly.

According to a new technical market research report, 'Diabetes Therapies and Diagnostics' from BCC Research, the global market value for diabetes therapies and diagnostics is an estimated $38 billion in 2010, but is expected to increase to $51.2 billion in 2015, for a 5-year compound annual growth rate (CAGR) of 6.1 per cent. The largest segment of the market, insulin products (including administration devices), is estimated to be worth $16.4 billion in 2010, and is expected to increase at a CAGR of 6.1 per cent to reach $22 billion in 2015.

Monitoring devices and accessories, the second-largest segment, is expected to reach $14.1 billion in 2015, after increasing from the 2010 estimate of $11.3 billion at a CAGR of 4.5 per cent. The fastest-growing segment, oral hypoglycemic drugs, is projected to increase at a CAGR of 8 per cent, increasing from an estimated $10.3 billion in 2010 to $15.1 billion in 2015.

Projections: Growth by next 5-10 years

According to a new technical market research report, 'Diabetes Therapies and Diagnostics' from BCC Research, the global market value for diabetes therapies and diagnostics is an estimated $38 billion in 2010, but is expected to increase to $51.2 billion in 2015, for a 5-year compound annual growth rate (CAGR) of 6.1 percent.

 

 

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date September 29-30, 2016
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed Day 1 Day 2
Poster Opportunity Closed Click Here to View